Why energy transport in the heart fails in hypertrophic cardiomyopathy

Hypertrophic cardiomyopathy (HCM) is the most common hereditary heart disease. It causes the left ventricle to thicken, the ...
CURE

FDA Fast Tracks MT-125 for Glioblastoma

The FDA has granted fast track designation to MT-125 for the treatment of patients with glioblastoma. The U.S. Food and Drug ...
Targeted Oncology

FDA Grants Fast Track Status to MT-125 in Glioblastoma

MT-125, a dual small-molecule inhibitor, received FDA fast track designation for glioblastoma, facilitating expedited drug ...

Myosin Therapeutics Receives FDA Fast Track Designation for MT-125 in Glioblastoma

Myosin Therapeutics, Inc., a clinical-stage biotechnology company developing first-in-class therapies that modulate molecular ...
Nature

Myosin light chain kinase mediates sarcomere organization during cardiac hypertrophy in vitro

During the development of hypertrophy, cardiac myocytes increase organization of the sarcomere, a highly ordered contractile unit in striated muscle cells. Several hypertrophic agonists, such as ...

H.C. Wainwright Maintains a Buy on Edgewise Therapeutics (EWTX), Sets a $42 PT

Edgewise Therapeutics, Inc. (NASDAQ: EWTX) is one of the best small cap stocks with the highest upside. H.C. Wainwright ...